OS Therapies Incorporated
OSTX
$1.86
$0.031.64%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -39.37M | -35.27M | -28.75M | -18.28M | -14.28M |
| Total Depreciation and Amortization | 499.60K | 487.20K | 363.00K | 239.50K | 114.60K |
| Total Amortization of Deferred Charges | 1.11M | 1.11M | 1.04M | 0.00 | 338.30K |
| Total Other Non-Cash Items | 5.76M | 5.00M | 4.01M | 2.70M | 1.65M |
| Change in Net Operating Assets | 13.47M | 13.32M | 9.11M | 2.46M | 616.90K |
| Cash from Operations | -18.53M | -15.36M | -14.24M | -12.88M | -11.56M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -292.80K | -466.40K | -466.40K | -466.40K |
| Cash from Investing | 0.00 | -292.80K | -466.40K | -466.40K | -466.40K |
| Total Debt Issued | 1.84M | 1.84M | -- | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | 0.00 | -250.00K |
| Issuance of Common Stock | 16.05M | 13.72M | 10.34M | 8.75M | 7.71M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 600.00 | 1.05M | 7.10M | 7.10M |
| Repurchase of Preferred Stock | -600.00 | -600.00 | -600.00 | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.95M | -1.95M | -1.95M | -2.48M | 172.10K |
| Cash from Financing | 15.94M | 13.60M | 9.44M | 13.37M | 14.74M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.60M | -2.05M | -5.26M | 18.50K | 2.71M |